Certain directors of Zosano Pharma Corp are under investigation over potential misconduct. The investigation was announced for investors in NASDAQ:ZSAN shares in connection certain financial statements made by Zosano Pharma.
Shares of Zosano Pharma Corp declined from over $11.00 per share in March 2015 to as low as $0.70 per share on September 1, 2016.
Investors who purchased shares of Zosano Pharma Corp (NASDAQ:ZSAN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigation by a law firm focuses on focuses on whether certain directors of violated securities laws by issuing misleading information to investors. More specifically, the investigation will focus on whether the Company’s filings with the SEC concerning its January 2015 Initial Public Offering (“IPO”) was misleading.
Zosano Pharma Corp offered more than 6,500,000 shares of its common stock at $11.00 per share in connection with its IPO. Shares of Zosano Pharma Corp declined from over $11 in March 2015 to under $1 per share in less than two years.
On October 10, 2016, NASDAQ:ZSAN shares closed at $0.755 per share.
Those who purchased NASDAQ:ZSAN shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com